Table 3.
Frequency (%) of abnormal laboratory parameters among study participants
| Gender | HOMA-IR | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variable | Participants No. | All | Boys | Girls | p-value* | Non-insulin resistant (non-IR) | Insulin resistant (IR) | p-value* | ||||
| n (%) | Participants No. | n (%) | Participants No. | n (%) | Participants No. | n (%) | Participants No. | n (%) | ||||
| FPG (mmol/L) | 96 | 1 (1.04) | 45 | 1 (2.22) | 51 | 0 (0.00) | 0.281 | 40 | 0 (0.00) | 56 | 1 (1.79) | 0.407 |
| 2-h G (mmol/L) | 93 | 3 (3.23) | 45 | 1 (2.22) | 48 | 2 (4.17) | 0.602 | 39 | 2 (5.13) | 54 | 1 (1.85) | 0.388 |
| FI (uU/ml) | 96 | 58 (60.42) | 45 | 22 (48.89) | 51 | 36 (70.59) | 0.033 | 40 | 5 (12.5) | 56 | 53 (96.64) | 0.0009 |
| TC (mmol/L) | 88 | 5 (5.68) | 41 | 3 (7.32) | 47 | 2 (4.26) | 0.754 | 35 | 2 (5.71) | 53 | 3 (5.66) | 0.2710 |
| TG (mmol/L) | 88 | 30 (34.09) | 41 | 13 (31.71) | 47 | 17 (36.17) | 0.105 | 35 | 9 (25.71) | 53 | 21 (39.62) | 0.0111 |
| HOMA-IR | 96 | 56 (58.33) | 45 | 20 (44.44) | 51 | 36 (70.59) | 0.0096 | - | - | - | - | - |
*
Obtained from χ2 test for comparison of categorical variables;
1
Pearson χ2 = 1.15, df=1;
2
Pearson χ2 = 0.28, df=1;
3
Pearson χ2 = 4.71, df=1;
4
Pearson χ2 = 0.57, df=2;
5
Pearson χ2 = 4.57, df=2;
6
Pearson χ2 = 6.72, df=1;
7
Pearson χ2 = 0.72, df=1;
8
Pearson χ2 = 0.78, df=1;
9
Pearson χ2 = 65.83, df=1;
10
Pearson χ2 = 2.60, df=2;
11
Pearson χ2 = 8.75, df=2; FPG, fasting plasma glucose; 2-h G, plasma glucose two hours post the glucose load during the oral glucose tolerance test; FI, fasting insulin level; TC, total cholesterol; TG, triglycerides; HOMA-IR, homeostatic model assessment of insulin resistance.